Home/Filings/4/0001410384-19-000076
4//SEC Filing

MAPLES MICHAEL J 4

Accession 0001410384-19-000076

CIK 0001410384other

Filed

May 13, 8:00 PM ET

Accepted

May 14, 5:42 PM ET

Size

19.6 KB

Accession

0001410384-19-000076

Insider Transaction Report

Form 4
Period: 2019-05-10
Transactions
  • Sale

    Common Stock

    2019-05-10$71.15/sh44,817$3,188,7305,855 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2019-05-109,6150 total
    Exercise: $13.00From: 2014-04-19Exp: 2024-03-19Common Stock (9,615 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2019-05-105,0220 total
    Exercise: $24.89From: 2015-07-09Exp: 2022-06-09Common Stock (5,022 underlying)
  • Exercise/Conversion

    Common Stock

    2019-05-10$4.00/sh+28,000$112,00033,855 total
  • Exercise/Conversion

    Common Stock

    2019-05-10$13.00/sh+9,615$124,99543,470 total
  • Exercise/Conversion

    Common Stock

    2019-05-10$24.89/sh+5,022$124,99848,492 total
  • Exercise/Conversion

    Common Stock

    2019-05-10$27.86/sh+2,180$60,73550,672 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2019-05-1028,0000 total
    Exercise: $4.00From: 2013-02-08Exp: 2022-02-08Common Stock (28,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2019-05-102,1802,306 total
    Exercise: $27.86From: 2016-07-09Exp: 2023-06-09Common Stock (2,180 underlying)
Footnotes (5)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.415 to $72.28 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]This option grant vested as to 1/4 of the total option grant on February 8, 2013, and thereafter as to 1/48 of the total option grant monthly. The option grant becomes exercisable as it vests.
  • [F3]The option grant vests and becomes exercisable in equal monthly installments over 36 months beginning on April 19, 2014.
  • [F4]The option grant vests and becomes exercisable in equal monthly installments over 36 months beginning on July 9, 2015.
  • [F5]The option grant vests and becomes exercisable in equal monthly installments over 36 months beginning on July 9, 2016.

Issuer

Q2 Holdings, Inc.

CIK 0001410384

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001055830

Filing Metadata

Form type
4
Filed
May 13, 8:00 PM ET
Accepted
May 14, 5:42 PM ET
Size
19.6 KB